LAG Time in the Era of Immunotherapy—New Molecular Insights Into the Immunosuppression Mechanism of Lymphocyte Activation Gene‐3
VC Luca - Immunological Reviews, 2025 - Wiley Online Library
The immune checkpoint receptor lymphocyte activation gene‐3 (LAG3) inhibits T‐cell
activation and was recently validated as a target for cancer immunotherapy. Despite its …
activation and was recently validated as a target for cancer immunotherapy. Despite its …